CW January 2006

category image Volume 15
Issue Number 1
January 2006
ISSN 10593802

New Drug to Avoid Severe Side Effects of Thyroid Cancer Treatment

The use of genetically engineered thyroid stimulating hormone before adjuvant radioiodine therapy in thyroid cancer patients avoids the previous need to withhold the hormone treatment for these patients.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Journal of Clinical Endocrinology and Metabolism online edition, December 29, 2005.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW January 2006

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login